Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture
- PMID: 7901801
- DOI: 10.1016/0306-4522(93)90307-2
Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture
Abstract
Transforming growth factor alpha messenger RNA and protein levels are highest in the striatum, the target area of mesencephalic dopaminergic neurons of the substantia nigra, suggesting a role as a target-derived neurotrophic factor for these cells. To test this hypothesis, we characterized the actions of transforming growth factor alpha on fetal rat dopaminergic neurons in culture. Transforming growth factor alpha promoted dopamine uptake in a dose- and time-dependent manner. Administration of transforming growth factor alpha at the time of plating for 2 h produced a significant increase in dopamine uptake after five days of growth in vitro. As cultures aged they became less responsive to transforming growth factor alpha, such that longer times of exposure were required to elicit a similar, but weaker, response. Dopaminergic cell survival was selectively promoted by transforming growth factor alpha, since there was an increase in the number of tyrosine hydroxylase-immunostained cells without a parallel increase in the total number of neuron-specific enolase-immunopositive cells. Neurite length, branch number and soma area of tyrosine hydroxylase-immunopositive cells also were enhanced by transforming growth factor alpha treatment. Increases in each of the dopaminergic parameters due to transforming growth factor alpha were accompanied by a rise in glial cell number, making it possible that these effects were mediated by this cell population. The neurotrophin antagonist, K252b, failed to inhibit the transforming growth factor alpha-induced increase in dopamine uptake, indicating that transforming growth factor alpha's effects were not mediated by neurotrophin mechanisms. The actions of transforming growth factor alpha on the differentiation of dopaminergic neurons only partially overlapped with those of epidermal growth factor. Thus, while transforming growth factor alpha and epidermal growth factor are believed to share the same receptor they differentially affect dopaminergic cell development in vitro. These results indicate that transforming growth factor alpha is a trophic factor for mesencephalic cells in culture and suggests that transforming growth factor alpha plays a physiological role in the development of these cells in vivo.
Similar articles
-
The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture.Neuroscience. 1993 Feb;52(4):855-66. doi: 10.1016/0306-4522(93)90534-m. Neuroscience. 1993. PMID: 8095710
-
Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity.Neuroscience. 1994 Dec;63(4):1189-96. doi: 10.1016/0306-4522(94)90583-5. Neuroscience. 1994. PMID: 7700516
-
Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.J Neurochem. 1997 Sep;69(3):986-94. doi: 10.1046/j.1471-4159.1997.69030986.x. J Neurochem. 1997. PMID: 9282920
-
Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning.J Neural Transm Suppl. 2003;(65):197-203. doi: 10.1007/978-3-7091-0643-3_12. J Neural Transm Suppl. 2003. PMID: 12946057 Review.
-
Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases.Prog Brain Res. 2004;146:168-83. doi: 10.1016/s0079-6123(03)46012-3. Prog Brain Res. 2004. PMID: 14699964 Review.
Cited by
-
Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview.Cell Mol Neurobiol. 2022 May;42(4):891-916. doi: 10.1007/s10571-020-00989-x. Epub 2020 Nov 5. Cell Mol Neurobiol. 2022. PMID: 33151415 Free PMC article. Review.
-
Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.Neurotox Res. 2000;2(2-3):115-37. doi: 10.1007/BF03033789. Neurotox Res. 2000. PMID: 16787836
-
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.Front Neuroanat. 2007 Dec 30;1:4. doi: 10.3389/neuro.05.004.2007. eCollection 2007. Front Neuroanat. 2007. PMID: 18958198 Free PMC article.
-
Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts.Exp Brain Res. 1994;101(1):73-85. doi: 10.1007/BF00243218. Exp Brain Res. 1994. PMID: 7843304
-
Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.Psychopharmacology (Berl). 2007 Apr;191(3):783-92. doi: 10.1007/s00213-006-0595-9. Epub 2006 Nov 10. Psychopharmacology (Berl). 2007. PMID: 17096084
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials